title: Zebrafish as a new model for herpes simplex virus type 1 infection.
abstract: The zebrafish (Danio rerio) is rapidly gaining ground as a disease model. However, until now, the use of this species with human pathogens has been restricted to just three bacteria; no studies involving viruses that infect humans are recorded. In this study, the zebrafish was used as a model of herpes simplex virus type 1 (HSV-1) infection of the nervous system. Fish infected using viral culture supernatants showed detectable HSV-1 DNA concentrations 1-4 days after inoculation, indicating that this virus can experimentally infect and persist in this host. The kinetics of infection was dose dependent, especially in the head. Histological immunodetection of HSV-1 glycoproteins confirmed the presence of HSV-1 in the organs studied; infection led to histopathological changes. Moreover, the suppression of the immune system by cyclophosphamide and the antiviral effect of acyclovir were demonstrated. The infection of the encephalon was studied in detail, and the time course of viral colonization recorded. Immunofluorescence studies provided immunoreactive evidence of viral antigens in the encephalon and spinal cord. Viruses cleared from infected brains showed the ability to infect human neuroblastoma cells. This study is the first to demonstrate HSV-1 infection in the zebrafish and manifests the potential use of this species in herpesvirus studies.
authors.affiliation: Drug Discovery Unit, NEURON BioPharma , Edificio BIC, Avda. Innovación 1, Armilla, Spain. jburgos@neuronbp.com
authors.forename: Javier S
authors.initials: JS
authors.lastname: Burgos
authors.forename: Jorge
authors.initials: J
authors.lastname: Ripoll-Gomez
authors.forename: Juan M
authors.initials: JM
authors.lastname: Alfaro
authors.forename: Isabel
authors.initials: I
authors.lastname: Sastre
authors.forename: Fernando
authors.initials: F
authors.lastname: Valdivieso
mesh_terms: D000212:Acyclovir / Q000627:therapeutic use; D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000009:adverse effects; D004195:Disease Models, Animal; D005260:Female; D006561:Herpes Simplex / Q000473:pathology / Q000821:virology*; D018259:Herpesvirus 1, Human / Q000502:physiology*; D007166:Immunosuppressive Agents / Q000009:adverse effects; D008297:Male; D013997:Time Factors; D015027:Zebrafish
chemical_list: D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D000212:Acyclovir